These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
802 related items for PubMed ID: 24321772
1. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ. Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772 [Abstract] [Full Text] [Related]
2. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats. Hara H, Suzuki A, Kunugi A, Tajima Y, Yamada R, Kimura H. Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652 [Abstract] [Full Text] [Related]
3. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression. Yang B, Zhang JC, Han M, Yao W, Yang C, Ren Q, Ma M, Chen QX, Hashimoto K. Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193 [Abstract] [Full Text] [Related]
4. The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptors. Sayson LV, Botanas CJ, Custodio RJP, Abiero A, Kim M, Lee HJ, Kim HJ, Yoo SY, Lee KW, Ryu HW, Acharya S, Kim KM, Lee YS, Cheong JH. Psychopharmacology (Berl); 2019 Jul; 236(7):2201-2210. PubMed ID: 30891619 [Abstract] [Full Text] [Related]
5. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice. Shen M, Lv D, Liu X, Li S, Chen Y, Zhang Y, Wang Z, Wang C. Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917 [Abstract] [Full Text] [Related]
6. Potential link between antidepressant-like effects of ketamine and promotion of adult neurogenesis in the ventral hippocampus of mice. Yamada J, Jinno S. Neuropharmacology; 2019 Nov 01; 158():107710. PubMed ID: 31310776 [Abstract] [Full Text] [Related]
7. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats. Pałucha-Poniewiera A, Szewczyk B, Pilc A. Neuropharmacology; 2014 Jul 01; 82():59-68. PubMed ID: 24631968 [Abstract] [Full Text] [Related]
8. Tramadol pretreatment enhances ketamine-induced antidepressant effects and increases mammalian target of rapamycin in rat hippocampus and prefrontal cortex. Yang C, Li WY, Yu HY, Gao ZQ, Liu XL, Zhou ZQ, Yang JJ. J Biomed Biotechnol; 2012 Jul 01; 2012():175619. PubMed ID: 22577289 [Abstract] [Full Text] [Related]
9. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR. Akinfiresoye L, Tizabi Y. Psychopharmacology (Berl); 2013 Nov 01; 230(2):291-8. PubMed ID: 23732839 [Abstract] [Full Text] [Related]
10. TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats. Suzuki A, Murakami K, Tajima Y, Hara H, Kunugi A, Kimura H. Pharmacol Biochem Behav; 2019 Aug 01; 183():80-86. PubMed ID: 31202810 [Abstract] [Full Text] [Related]
11. Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner. Holubova K, Kleteckova L, Skurlova M, Ricny J, Stuchlik A, Vales K. Psychopharmacology (Berl); 2016 Jun 01; 233(11):2077-2097. PubMed ID: 27004790 [Abstract] [Full Text] [Related]
12. Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling. Cavalleri L, Merlo Pich E, Millan MJ, Chiamulera C, Kunath T, Spano PF, Collo G. Mol Psychiatry; 2018 Apr 01; 23(4):812-823. PubMed ID: 29158584 [Abstract] [Full Text] [Related]
13. The involvement of AMPA-ERK1/2-BDNF pathway in the mechanism of new antidepressant action of prokinetic meranzin hydrate. Xie Y, Huang X, Hu SY, Zhang YJ, Wang Y, Qiu XJ, Ren P, Fan R, Zhang CH, Xie WB, Ji H, He J, Chen X, Xie L, Liu ZQ, Zhou HH. Amino Acids; 2013 Feb 01; 44(2):413-22. PubMed ID: 22782214 [Abstract] [Full Text] [Related]
14. Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test. Yang C, Hu YM, Zhou ZQ, Zhang GF, Yang JJ. Ups J Med Sci; 2013 Mar 01; 118(1):3-8. PubMed ID: 22970723 [Abstract] [Full Text] [Related]
15. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine. Yang C, Kobayashi S, Nakao K, Dong C, Han M, Qu Y, Ren Q, Zhang JC, Ma M, Toki H, Yamaguchi JI, Chaki S, Shirayama Y, Nakazawa K, Manabe T, Hashimoto K. Biol Psychiatry; 2018 Oct 15; 84(8):591-600. PubMed ID: 29945718 [Abstract] [Full Text] [Related]
16. Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test. Wang X, Yang Y, Zhou X, Wu J, Li J, Jiang X, Qu Q, Ou C, Liu L, Zhou S. Psychiatry Res; 2011 Jan 30; 185(1-2):248-53. PubMed ID: 20580983 [Abstract] [Full Text] [Related]
17. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats. Koike H, Chaki S. Behav Brain Res; 2014 Sep 01; 271():111-5. PubMed ID: 24909673 [Abstract] [Full Text] [Related]
18. Fast-acting antidepressant-like effects of ketamine in aged male rats. Hernández-Hernández E, Ledesma-Corvi S, Jornet-Plaza J, García-Fuster MJ. Pharmacol Rep; 2024 Oct 01; 76(5):991-1000. PubMed ID: 39158787 [Abstract] [Full Text] [Related]
19. The activation of adenosine monophosphate-activated protein kinase in rat hippocampus contributes to the rapid antidepressant effect of ketamine. Xu SX, Zhou ZQ, Li XM, Ji MH, Zhang GF, Yang JJ. Behav Brain Res; 2013 Sep 15; 253():305-9. PubMed ID: 23906767 [Abstract] [Full Text] [Related]
20. VGF function in depression and antidepressant efficacy. Jiang C, Lin WJ, Sadahiro M, Labonté B, Menard C, Pfau ML, Tamminga CA, Turecki G, Nestler EJ, Russo SJ, Salton SR. Mol Psychiatry; 2018 Jul 15; 23(7):1632-1642. PubMed ID: 29158577 [Abstract] [Full Text] [Related] Page: [Next] [New Search]